Hendrik Vilstrup Selected Research

Fatty Liver

11/2019	Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
10/2019	The Liver-α-Cell Axis and Type 2 Diabetes.
10/2018	Urea cycle dysregulation in non-alcoholic fatty liver disease.
3/2017	Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.
8/2015	Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
11/2014	Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats.
4/2014	Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease.
2/2012	Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children.
3/2003	[Nonalcoholic steatohepatitis--a "new" hepatic disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hendrik Vilstrup Research Topics

Disease

79	Fibrosis (Cirrhosis) 08/2023 - 03/2002
41	Hepatic Encephalopathy 12/2023 - 01/2003
30	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 05/2002
27	Ascites 01/2023 - 12/2003
20	Non-alcoholic Fatty Liver Disease 07/2023 - 03/2003
20	Liver Diseases (Liver Disease) 01/2022 - 01/2010
19	Hemorrhage 01/2023 - 05/2002
15	Inflammation (Inflammations) 07/2023 - 04/2010
13	Portal Hypertension 12/2023 - 01/2003
12	Infections 01/2023 - 01/2003
11	Alcoholic Hepatitis 03/2021 - 09/2011
11	Hyperammonemia 01/2021 - 06/2007
10	Insulin Resistance 01/2022 - 03/2003
9	Liver Failure 01/2021 - 01/2003
9	Fatty Liver 11/2019 - 03/2003
8	Neoplasms (Cancer) 01/2023 - 01/2002
8	Alcoholic Fatty Liver 11/2019 - 04/2014
8	End Stage Liver Disease 01/2019 - 01/2010
7	Acute-Phase Reaction 01/2017 - 02/2005
6	Hepatolenticular Degeneration (Wilson's Disease) 11/2023 - 10/2021
5	Necrosis 01/2021 - 01/2011
5	Varicose Veins (Varicose Vein) 10/2018 - 03/2003
4	Hyponatremia 12/2023 - 10/2018
4	Brain Diseases (Brain Disorder) 01/2021 - 01/2003
4	Glucose Intolerance 10/2019 - 06/2005
4	Peritonitis 01/2019 - 12/2003
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 10/2017 - 08/2005
3	Obesity 01/2022 - 10/2019
3	Disease Progression 03/2021 - 03/2017
3	Chronic Hepatitis C 01/2020 - 11/2006
3	Chronic Disease (Chronic Diseases) 01/2020 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 09/2014
3	Hepatorenal Syndrome 05/2016 - 01/2016
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 02/2011 - 05/2010
2	Liver Neoplasms (Liver Cancer) 07/2023 - 09/2014
2	Cognitive Dysfunction 03/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

23	AmmoniaIBA 07/2023 - 01/2006
20	Urea (Carbamide)FDA LinkGeneric 07/2023 - 02/2005
15	satavaptanIBA 01/2023 - 01/2012
14	SodiumIBA 11/2022 - 08/2005
13	EnzymesIBA 07/2023 - 02/2005
13	Insulin (Novolin)FDA Link 01/2022 - 03/2002
13	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 06/2005
13	Lactulose (Duphalac)FDA LinkGeneric 10/2019 - 06/2013
12	Galactose (Galactopyranose)FDA LinkGeneric 02/2023 - 02/2005
11	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2003
11	Branched-Chain Amino AcidsIBA 04/2018 - 03/2009
10	NitrogenIBA 01/2020 - 02/2005
8	DiureticsIBA 11/2022 - 01/2007
8	Amino Acids FDA Link 01/2021 - 03/2009
8	Messenger RNA (mRNA)IBA 11/2019 - 02/2005
7	Glutamine (L-Glutamine)FDA Link 01/2021 - 01/2006
7	LipopolysaccharidesIBA 01/2017 - 02/2005
6	AlbuminsIBA 01/2023 - 06/2010
6	Proton Pump InhibitorsIBA 01/2023 - 10/2016
6	Insulin-Like Growth Factor I (IGF-1)IBA 08/2015 - 08/2006
5	CopperIBA 11/2023 - 06/2020
5	Glucagon (Glukagon)FDA Link 01/2023 - 01/2018
5	Rifaximin (L 105)FDA Link 01/2023 - 06/2013
5	Alanine (L-Alanine)FDA Link 01/2021 - 09/2011
5	EndotoxinsIBA 03/2017 - 07/2007
5	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2016 - 09/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2007
4	BilirubinIBA 01/2022 - 09/2011
4	Oxygen (Dioxygen)IBA 12/2014 - 03/2009
3	PotassiumIBA 01/2023 - 08/2005
3	Glucagon Receptors (Glucagon Receptor)IBA 01/2023 - 10/2019
3	CreatinineIBA 01/2022 - 09/2011
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2020
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2014
3	Vasopressins (Vasopressin)IBA 11/2019 - 06/2013
3	LipidsIBA 10/2019 - 03/2003
3	BenzodiazepinesIBA 04/2018 - 11/2015
3	CytokinesIBA 01/2018 - 09/2016
3	Neomycin FDA LinkGeneric 01/2017 - 02/2015
3	Interleukin-6 (Interleukin 6)IBA 06/2016 - 04/2011
3	DisaccharidesIBA 05/2016 - 01/2016
3	lactitolIBA 05/2016 - 01/2016
3	Tricarboxylic AcidsIBA 04/2011 - 06/2007
2	Antidiuretic Hormone Receptor AntagonistsIBA 01/2023 - 11/2015
2	CholesterolIBA 12/2022 - 11/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2022 - 06/2011
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 11/2015
2	ZincIBA 01/2022 - 01/2022
2	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 11/2015
2	Protons (Proton)IBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 02/2021 - 06/2010
2	SteroidsIBA 01/2021 - 01/2004
2	InterleukinsIBA 01/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2020 - 08/2014
2	Carrier Proteins (Binding Protein)IBA 01/2020 - 09/2014

Therapy/Procedure

14	Transjugular Intrahepatic Portasystemic Shunt 12/2023 - 01/2003
10	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2023 - 01/2003
10	Therapeutics 01/2022 - 08/2007
3	Resistance Training 08/2023 - 01/2019
3	Liver Transplantation 01/2019 - 03/2003
3	Ligation 11/2008 - 09/2006
2	Activities of Daily Living (ADL) 03/2022 - 01/2021
2	Bariatric Surgery 01/2021 - 08/2015